Approval · Notice of Compliance 31170 · 2023
PADCEV: Notice of Compliance 31170
Issued July 7, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 31170
- Date
- July 7, 2023
- Company
- Seagen Inc.
- Product type
- Biologic
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update to the Product Monograph
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PADCEV | Not yet assigned | — |
Medicinal ingredients
- ENFORTUMAB VEDOTIN 20 MG per VIAL
- ENFORTUMAB VEDOTIN 30 MG per VIAL